Volume 27, Issue 2 - Public Disclosure

Clinical data publication by the EMA: The challenges facing the pharmaceutical industry

Authors: Wendelgard Pisternick-Ruf, Alexandra Marquart, Thomas M. Schindler

Abstract

Download the full article

References

1. European Medicines Agency. Clinical data publication [cited 2018 Jan 25]. Available from: Available from: http://www.ema.europa.eu/ema/?curl=pages/special_topics/general/general_content_000555.jsp
2. Transparency International UK. Clinical Trial Transparency – A Guide for Policy Makers. December 2017 [cited 2018 Jan 17]. Available from: Available from: http://www.transparency.org.uk/publications/clinical-trial-transparency/#.Wl9s_K7ibRY
3. European Medicines Agency. European Medicines Agency policy on publication of clinical data for medicinal products for human use, POLICY/0070, effective date: 1 January 2015 [cited 2018 Jan 17]. Available from: Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2014/10/WC500174796.pdf
4. Health Canada. Regulations Amending the Food and Drug Regulations (Public release of Clinical Information), Vol 151, No. 49 – December 9, 2017 [cited 2018 Jan 17]. Available from: Available from: http://gazette.gc.ca/rp-pr/p1/2017/2017-12-09/html/reg3-eng.html
5. Food and Drug Administration. Clinical Data Summary Pilot Program [cited 2018 Jan 17]. Available from: Available from: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm589210.htm
6. PhRMA and EFPIA. Principles for Responsible Clinical Trial Data Sharing – Our Commitment to Patients and Researchers, July 18, 2013 [cited 2018 Jan 25]. Available from: Available from: https://www.efpia.eu/media/25666/ principles-for-responsibleclinical-trial-data-sharing.pdf
7. BI Policy on Transparency and Publication of Clinical Study Data [cited 2018 Jan 19]. Available from: Available from: https://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/documents/Policy.pdf
8. European Medicines Agency, Media and Public relations. Unparalleled access to clinical data – one year on, EMA/682188/ 2017, 18 October 2017 [cited 2018 Jan 26]. Available from: Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2017/10/WC500237031.pdf
9. European Medicines Agency. European Medicines Agency policy on access to documents (related to medicinal products for human and veterinary use, POLICY/ 0043, effective date: 1 December 2010 [cited 2018 Jan 26]. Available from: Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2010/11/WC500099473.pdf
10. Bonini S, Eichler HG, Wathion N, Rasi G. Transparency and the European Medicines Agency – Sharing of Clinical Trial Data. N Engl J Med 2014; 371(26): 2452–5.
11. European Medicines Agency. External guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use; Version 1.3, published 22 September 2017 [cited 2018 Jan 17]. Available from: Available from: http://www.ema. europa.eu/docs/en_GB/document_library /Regulatory_and_procedural_guideline/ 2017/09/ WC500235371.pdf.
12. Regulation (EC) No 726/2004 of the European Parliament and the Council of 31 March 2004 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. Off J Eur Union, 30 April 2004: L 136/1-L 136/33.
13. TransCelerate Biopharma Inc. Protection of Personal Data in Clinical Documents – A Model Approach. [cited 2018 Jan 22]. Available from: Available from: http://www.transceleratebiopharmainc.com/wp-content/uploads/2017/02/Protection-of-Personal-Data-in-Clinical-Documents.pdf
14. Presentation – European Medicines Agency update on Clinical Data Publication (CDP) (Anne-Sophie Henry-Eude). First published on 7 February 2018. [cited 2018 Feb 21]. Available from: Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Presentation/2018/02/WC500243177.pdf
15. ClinicalTrials.gov. Checklist for Evaluating Whether a Clinical Trial or Study is an Applicable Clinical Trial (ACT) Under 42 CFR 11.22(b) for Clinical Trials Initiated on or After January 18, 2017 (NOT FOR SUBMISSION [cited 2018 Jan 19]. Available from: Available from: https://prsinfo.clinicaltrials.gov/ACT_Checklist.pdf
16. Department of Health and Human Services, 42 CRF Part 11, Clinical Trials Registration and Results Information Submission; Final Rule. Federal Register September 21, 2016; Vol. 81, No. 183: 64982–65157. Available from: Available from: https://www.gpo.gov/fdsys/pkg/FR-2016-09-21/pdf/2016-22129.pdf
17. ICMJE. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, Updated December 2017. [cited 2018 Jan 22]. Available from: Available from: http://www.icmje.org/icmje-recommendations.pdf